Literature DB >> 18365687

Effects of carbamazepine and amitriptyline on tetrodotoxinresistant Na+ channels in immature rat trigeminal ganglion neurons.

Yun-Kyung Hur1, In-Sun Choi, Jin-Hwa Cho, Eun-Joo Park, Jae-Kap Choi, Byung-Ju Choi, Il-Sung Jang.   

Abstract

Although anticonvulsant drugs that block voltage-dependent Na+ channels have been widely used for neuropathic pain, including peripheral nerve injury-induced pain, much less is known about the actions of these drugs on immature trigeminal ganglion (TG) neurons. Here we report the effects of carbamazepine (CBZ) and amitriptyline (ATL) on tetrodotoxin-resistant (TTX-R) Na' channels expressed on immature rat TG neurons. TTX-R Na+ currents (I(Na)) were recorded in the presence of 300 nM TTX by use of a conventional whole-cell patch clamp method. Both CBZ and ATL inhibited TTX-R I(Na) in a concentration-dependent manner, but ATL was more potent. While CBZ and ATL did not affect the overall voltage-activation relationship of TTX-R Na+ channels, both drugs shifted the voltage-activation relationship to the left, indicating that they inhibited TTX-R Na+ channels more efficiently at depolarized membrane potentials. ATL showed a profound use-dependent blockade of TTX-R I(Na), but CBZ had little effect. The present results suggest that both CBZ and ATL, common drugs used for treating neuropathic pain, efficiently inhibit TTX-R Na+ channels expressed on immature TG neurons, and that these drugs might be useful for the treatment of trigeminal nerve injury-induced neuropathic pain, as well as the inhibition of ongoing central sensitization, even during immature periods.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18365687     DOI: 10.1007/s12272-001-1138-x

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  9 in total

1.  Antinociceptive action of carbamazepine on thermal hypersensitive pain at spinal level in a rat model of adjuvant-induced chronic inflammation.

Authors:  Tatsushige Iwamoto; Yoshihiro Takasugi; Hideaki Higashino; Hiroyuki Ito; Yoshihisa Koga; Shinichi Nakao
Journal:  J Anesth       Date:  2010-11-27       Impact factor: 2.078

2.  Blockade of Nav1.8 currents in nociceptive trigeminal neurons contributes to anti-trigeminovascular nociceptive effect of amitriptyline.

Authors:  Jingyao Liang; Xiaoyan Liu; Meiyan Pan; Wei Dai; Zhao Dong; Xiaolin Wang; Ruozhuo Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Neuromolecular Med       Date:  2013-11-30       Impact factor: 3.843

3.  Low concentrations of amitriptyline inhibit nicotinic receptors in unmyelinated axons of human peripheral nerve.

Authors:  A Freysoldt; J Fleckenstein; P M Lang; D Irnich; P Grafe; R W Carr
Journal:  Br J Pharmacol       Date:  2009-08-19       Impact factor: 8.739

4.  Diabetes mellitus contributes to carbamazepine resistance in patient with trigeminal neuralgia.

Authors:  Anke Zhang; Wenbo Zhang; Houshi Xu; Chenqi Guo; Ling Yuan; Yuanzhi Xu; Jie Ren; Lingzhao Min; Qiuyang Sun; Meiqing Lou; Lili Wei; Shaojian Lin
Journal:  Neurosurg Rev       Date:  2020-04-24       Impact factor: 3.042

5.  The anticonvulsant enaminone E139 attenuates paclitaxel-induced neuropathic pain in rodents.

Authors:  Dhandapani Thangamani; Ivan Ogheneochuko Edafiogho; Willias Masocha
Journal:  ScientificWorldJournal       Date:  2013-12-08

6.  Depression and anxiety behaviour in a rat model of chronic migraine.

Authors:  Mingjie Zhang; Yufei Liu; Mangsuo Zhao; Wenjing Tang; Xiaolin Wang; Zhao Dong; Shengyuan Yu
Journal:  J Headache Pain       Date:  2017-02-21       Impact factor: 7.277

7.  Effect of carbamazepine on tetrodotoxin-resistant Na+ channels in trigeminal ganglion neurons innervating to the dura.

Authors:  Jin-Eon Han; Jin-Hwa Cho; Michiko Nakamura; Maan-Gee Lee; Il-Sung Jang
Journal:  Korean J Physiol Pharmacol       Date:  2018-10-25       Impact factor: 2.016

8.  Effect of amitriptyline on tetrodotoxin-resistant Nav1.9 currents in nociceptive trigeminal neurons.

Authors:  Jingyao Liang; Xiaoyan Liu; Jianquan Zheng; Shengyuan Yu
Journal:  Mol Pain       Date:  2013-06-22       Impact factor: 3.395

9.  Ambroxol for the treatment of fibromyalgia: science or fiction?

Authors:  Kai-Uwe Kern; Myriam Schwickert
Journal:  J Pain Res       Date:  2017-08-16       Impact factor: 3.133

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.